{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T11:18:52Z","timestamp":1773227932257,"version":"3.50.1"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"abstract":"<jats:p>In September 2015, the U.S. Food and Drug Administration (FDA) convened a meeting of the Obstetrics and Gynecology Advisory Board Committee to address the sudden increase of patient-reported adverse events surrounding Essure, a Class III device offering a less invasive method for permanent female sterilization. After a review of the premarketing and postmarketing data and existing scientific literature, the FDA concluded there was insufficient evidence to remove the device from the market. However, the FDA did release a new guidance document requiring a black box warning for the device and ordered a new postmarketing study comparing Essure\u2019s safety and efficacy with laparoscopic tubal sterilization. The device was first approved in 2002 based on nonrandomized, single-arm prospective clinical studies. Since its approval, the device has grown in popularity, particularly in the United States. The driving forces for the sudden increase in adverse event reporting starting in 2013 related to the device remain unclear. Until completion of the new postmarketing study, there will continue to be significant uncertainty of the technology's risk\u2013benefit profile. The controversy with Essure underscores the need for obstetricians and gynecologists to be actively involved in the lifecycle of medical devices. This includes actively reporting adverse events associated with devices to the FDA, supporting the implementation of unique device identifiers enriched with clinical records and paired with insurance claims, and stewarding robust device-specific registries.<\/jats:p>","DOI":"10.1097\/aog.0000000000001796","type":"journal-article","created":{"date-parts":[[2016,12,7]],"date-time":"2016-12-07T13:59:24Z","timestamp":1481119164000},"page":"10-19","source":"Crossref","is-referenced-by-count":29,"title":["Hysteroscopic Sterilization With Essure"],"prefix":"10.1097","volume":"129","author":[{"given":"Jessica R.","family":"Walter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Comeron W.","family":"Ghobadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Hayman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230711","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1097\/AOG.0000000000001430","article-title":"Medical device approvals through the premarket approval pathway in obstetrics and gynecology from 2000 to 2015: process and problems","volume":"127","author":"Walter","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R3-20230711","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jmig.2010.10.010","article-title":"Confirmation of Essure placement using transvaginal ultrasound","volume":"18","author":"Veersema","year":"2011","journal-title":"J Minim Invasive Gynecol"},{"key":"R7-20230711","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1056\/NEJMp1510514","article-title":"Revisiting Essure\u2014toward safe and effective sterilization","volume":"373","author":"Dhruva","year":"2015","journal-title":"N Engl J Med"},{"key":"R8-20230711","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jmig.2015.04.017","article-title":"Hysteroscopic Essure inserts for permanent contraception: extended follow-up results of a phase iii multicenter international study","volume":"22","author":"Chudnoff","year":"2015","journal-title":"J Minim Invasive Gynecol"},{"key":"R9-20230711","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jmig.2014.12.002","article-title":"Essure hysteroscopic sterilization versus interval laparoscopic bilateral tubal ligation: a comparative effectiveness review","volume":"22","author":"Ouzounelli","year":"2015","journal-title":"J Minim Invasive Gynecol"},{"key":"R10-20230711","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.contraception.2012.08.006","article-title":"Pregnancies after hysteroscopic sterilization: a systematic review","volume":"87","author":"Cleary","year":"2013","journal-title":"Contraception"},{"key":"R11-20230711","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.2214\/AJR.11.7667","article-title":"Necessity of hysterosalpingography after Essure microinsert placement for contraception","volume":"198","author":"Lazarus","year":"2012","journal-title":"AJR Am J Roentgenol"},{"key":"R12-20230711","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1471-0528.2012.03292.x","article-title":"Complications of hysteroscopic Essure(\u00ae) sterilisation: report on 4306 procedures performed in a single centre","volume":"119","author":"Povedano","year":"2012","journal-title":"BJOG"},{"key":"R13-20230711","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.annemergmed.2010.09.024","article-title":"Ruptured ectopic pregnancy after previously confirmed tubal occlusion by the Essure procedure","volume":"57","author":"Bjornsson","year":"2011","journal-title":"Ann Emerg Med"},{"key":"R14-20230711","first-page":"337","article-title":"Ectopic pregnancy after hysteroscopic tubal occlusion confirmed by hysterosalpingogram: a case report","volume":"58","author":"Huguelet","year":"2013","journal-title":"J Reprod Med"},{"key":"R15-20230711","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.gyobfe.2009.03.024","article-title":"Essure implants for tubal sterilisation in France [in French]","volume":"37","author":"Grosdemouge","year":"2009","journal-title":"Gynecol Obstet Fertil"},{"key":"R16-20230711","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S1701-2163(16)34798-3","article-title":"Outcomes in the ultrasound follow-up of the Essure micro-insert: complications and proper placement","volume":"33","author":"Thiel","year":"2011","journal-title":"J Obstet Gynaecol Can"},{"key":"R17-20230711","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jmig.2014.06.007","article-title":"Incidence and risk factors for chronic pelvic pain after hysteroscopic sterilization","volume":"22","author":"Yunker","year":"2015","journal-title":"J Minim Invasive Gynecol"},{"key":"R18-20230711","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/CIRCOUTCOMES.114.001460","article-title":"Medical device postapproval safety monitoring: where does the United States stand?","volume":"8","author":"Rajan","year":"2015","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"R19-20230711","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/pds.3766","article-title":"Incidence of opioid-managed pelvic pain after hysteroscopic sterilization versus laparoscopic sterilization, US 2005-2012","volume":"24","author":"Conover","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R20-20230711","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.contraception.2011.01.008","article-title":"Mechanism of action of the Adiana(\u00ae) device: a histologic perspective","volume":"84","author":"Vancaillie","year":"2011","journal-title":"Contraception"},{"key":"R21-20230711","first-page":"118","article-title":"Long-term effect of tubal sterilization on menstrual indices and pelvic pain","volume":"82","author":"Rulin","year":"1993","journal-title":"Obstet Gynecol"},{"key":"R24-20230711","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jama.2013.284986","article-title":"FDA approval of cardiac implantable electronic devices via original and supplement premarket approval pathways, 1979-2012","volume":"311","author":"Rome","year":"2014","journal-title":"JAMA"},{"key":"R25-20230711","doi-asserted-by":"crossref","first-page":"798","DOI":"10.7326\/M13-2931","article-title":"Premarket approval supplement pathway: do we know what we are getting?","volume":"160","author":"Zheng","year":"2014","journal-title":"Ann Intern Med"},{"key":"R26-20230711","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.fertnstert.2011.06.047","article-title":"A comparison of novice and experienced physicians performing hysteroscopic sterilization: an analysis of an FDA-mandated trial","volume":"96","author":"Levie","year":"2011","journal-title":"Fertil Steril"},{"key":"R29-20230711","article-title":"Erin Brockovic calls for end to Bayer's Essure","author":"Morris","year":"2014","journal-title":"BBC News"},{"key":"R30-20230711","article-title":"Essure\u2019 birth control subject of potential class-action lawsuit in Canada","author":"McKnight","year":"2016","journal-title":"Toronto Star"},{"key":"R32-20230711","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/1468-0009.12044","article-title":"Regulatory reticence and medical devices","volume":"92","author":"Fox","year":"2014","journal-title":"Milbank Q"},{"key":"R33-20230711","article-title":"Bill would require doctors to report medical-device hazards","author":"Levitz","year":"2016","journal-title":"Wall Street J"},{"key":"R34-20230711","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/1468-0009.12043","article-title":"Improving medical device regulation: the United States and Europe in perspective","volume":"92","author":"Sorenson","year":"2014","journal-title":"Milbank Q"},{"key":"R36-20230711","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1001\/jamainternmed.2014.4194","article-title":"Assessing the safety and effectiveness of devices after US Food and Drug Administration approval: FDA-mandated postapproval studies","volume":"174","author":"Reynolds","year":"2014","journal-title":"JAMA Intern Med"},{"key":"R37-20230711","doi-asserted-by":"crossref","first-page":"i3323","DOI":"10.1136\/bmj.i3323","article-title":"Comparison of rates of safety issues and reporting of trial outcomes for medical devices approved in the European Union and United States: cohort study","volume":"353","author":"Hwang","year":"2016","journal-title":"BMJ"},{"key":"R39-20230711","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1001\/jama.2016.8708","article-title":"Need for a national evaluation system for health technology","volume":"316","author":"Shuren","year":"2016","journal-title":"JAMA"},{"key":"R41-20230711","article-title":"Medical device user fee amendments performance goals and procedures, fiscal years 2018 through 2022\u2013draft guidance"},{"key":"R43-20230711","article-title":"Medicare backs ID numbers for medical devices","author":"Burton","year":"2016","journal-title":"Wall Street J"},{"key":"R44-20230711","article-title":"How safety concerns about Essure reveal a path to better device tracking","author":"Graham","journal-title":"Health Affairs Blog"},{"key":"R45-20230711","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1056\/NEJMhle1113918","article-title":"Regulation of medical devices in the United States and European Union","volume":"366","author":"Kramer","year":"2012","journal-title":"N Engl J Med"},{"key":"R46-20230711","doi-asserted-by":"crossref","first-page":"e1001276","DOI":"10.1371\/journal.pmed.1001276","article-title":"How does medical device regulation perform in the United States and the European Union? A systematic review","volume":"9","author":"Kramer","year":"2012","journal-title":"PLoS Med"},{"key":"R47-20230711","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1001\/jama.2009.1899","article-title":"Strength of study evidence examined by the FDA in premarket approval of cardiovascular devices","volume":"302","author":"Dhruva","year":"2009","journal-title":"JAMA"},{"key":"R48-20230711","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1007\/s10620-016-4117-2","article-title":"Overview of high-risk medical device innovation in gastroenterology from 2000 to 2014: enhancing the pipeline","volume":"61","author":"Saleem","year":"2016","journal-title":"Dig Dis Sci"},{"key":"R49-20230711","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1097\/AOG.0000000000001335","article-title":"The role of social networks, medical-legal climate, and patient advocacy on surgical options: a new era","volume":"127","author":"Tracy","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R51-20230711","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.healthpol.2013.08.008","article-title":"Registries of implantable medical devices in Europe","volume":"113","author":"Niederlander","year":"2013","journal-title":"Health Policy"},{"key":"R53-20230711","first-page":"23","article-title":"Sterilization in the United States","volume":"1","author":"Bartz","year":"2008","journal-title":"Rev Obstet Gynecol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006250-201701000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T19:10:49Z","timestamp":1689102649000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201701000-00003"}},"subtitle":["Summary of the U.S. Food and Drug Administration Actions and Policy Implications for Postmarketing Surveillance"],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000001796","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}